Subcutaneous Biologics

Daejeon, South Korea, August 5, 2026 Alteogen Inc. has entered into an exclusive license agreement with an undisclosed global...

SAN DIEGO and MENLO PARK, Calif., May 6, 2026 Halozyme Therapeutics and Oruka Therapeutics announced a global exclusive collaboration...

Cambridge, UK, 30 October 2025 – Alexion, AstraZeneca Rare Disease, today announced positive results from the global Phase III...